MaxCyte (NASDAQ:MXCT) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
MaxCyte missed estimated earnings by 10.0%, reporting an EPS of $-0.11 versus an estimate of $-0.1.
Revenue was down $2.64 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 10.44% drop in the share price the next day.
Here’s a look at MaxCyte’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.1 | -0.11 | -0.07 | -0.09 |
| EPS Actual | -0.1 | -0.11 | -0.05 | -0.06 |
| Revenue Estimate | 10.80M | 8.32M | 12.90M | 10.43M |
| Revenue Actual | 9.04M | 8.58M | 12.42M | 10.64M |
To track all earnings releases for MaxCyte visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
